Inactive Instrument
Epirus Biopharmaceuticals Inc Stock Nasdaq
Stocks
US29428P1075
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 746K 646K 603K 553K 1.04M 71.02M 1.06M 7.07M 2.78M 35.6M 2.8M 2.74M 118M | P/E 2014 |
-0.83x | P/E 2015 | -1.35x |
|---|---|---|---|---|---|
| Enterprise Value | -15.94M -13.78M -12.87M -11.81M -22.21M -1.52B -22.56M -151M -59.28M -760M -59.84M -58.53M -2.51B | EV / Sales 2014 |
14,770,294,750x | EV / Sales 2015 | 83,658,631x |
| Free-Float |
100% | Yield 2014 * |
-
| Yield 2015 | - |
| 1 day | -25.00% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -25.00% | -.--% | - | - | 26 | |
| +0.99% | +1.78% | +5.07% | +16.49% | 49.47B | |
| +3.71% | +9.40% | +486.14% | +579.98% | 43.97B | |
| +5.60% | +10.21% | +20.85% | +81.78% | 39.6B | |
| +2.70% | +1.57% | +32.71% | +9.07% | 39.29B | |
| +2.21% | +6.75% | +20.20% | +54.40% | 32.43B | |
| +2.23% | +4.71% | - | - | 16.84B | |
| +0.97% | +2.35% | +35.99% | +124.45% | 16.49B | |
| -0.11% | +2.41% | +5.03% | +20.47% | 14.01B | |
| +0.75% | +15.04% | +79.84% | +29.70% | 12.77B | |
| Average | -0.59% | +6.32% | +85.73% | +114.54% | 29.43B | |
| Weighted average by Cap. | +2.54% | +6.10% | +105.13% | +138.67% |
| 2014 | 2015 | |
|---|---|---|
| Net sales | 0 0 0 0 0.01 0.38 0.01 0.04 0.01 0.19 0.02 0.01 0.63 | 0.7 0.61 0.57 0.52 0.98 66.72 0.99 6.64 2.61 33.44 2.63 2.57 110.55 |
| Net income | -41.84M -36.2M -33.8M -31.01M -58.32M -3.98B -59.25M -397M -156M -2B -157M -154M -6.6B | -52.19M -45.14M -42.16M -38.67M -72.74M -4.97B -73.89M -495M -194M -2.49B -196M -192M -8.23B |
| Net Debt | -14.18M -12.27M -11.45M -10.51M -19.76M -1.35B -20.08M -134M -52.75M -676M -53.25M -52.08M -2.24B | -16.68M -14.43M -13.48M -12.36M -23.25M -1.59B -23.62M -158M -62.05M -796M -62.64M -61.27M -2.63B |
Employees
-
